Vycor Medical (VYCO) Net Income Growth (3y) (2013 - 2026)
Vycor Medical (VYCO) Net Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn | 280.49% |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 26.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.38% |
| Dec 31, 2025 | 23.21% |
| Sep 30, 2025 | 72.13% |
| Jun 30, 2025 | -12.45% |
| Mar 31, 2025 | 59.81% |
| Dec 31, 2024 | 62.14% |
| Sep 30, 2024 | 77.20% |
| Jun 30, 2024 | 83.19% |
| Mar 31, 2024 | 79.41% |
| Dec 31, 2023 | -28.18% |
| Sep 30, 2023 | 68.08% |
| Jun 30, 2023 | 56.28% |
| Mar 31, 2023 | 58.22% |
| Dec 31, 2022 | 70.94% |
| Sep 30, 2022 | 54.27% |
| Jun 30, 2022 | 67.31% |
| Mar 31, 2022 | -26.04% |
| Dec 31, 2021 | -26.05% |
| Sep 30, 2021 | -26.17% |
| Jun 30, 2021 | -26.25% |